Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Strategies for Preventing Antimicrobial Resistance

By HospiMedica staff writers
Posted on 01 Apr 2002
A campaign to prevent antimicrobial resistance in healthcare settings was announced by the US Centers for Disease Control and Prevention (Atlanta, USA) at the International Conference on Emerging Infectious Diseases in Atlanta.

The campaign comprises four key strategies. These are to prevent infection, diagnose and treat infection effectively, use antimicrobials wisely, and prevent the transmission of drug-resistant pathogens. Within these strategies are 12 specific action steps derived from evidence-based guidelines and recommendations that clinicians can use to prevent antimicrobial resistance in hospitalized adults.

Action Step 1 is to give influenza/S pneumonia vaccine to at-risk patients before discharge. Step 2 is to use catheters only when essential and remove them when no longer essential. Step 3 is to culture the patient, target empiric therapy to likely pathogens, and target definitive therapy to known pathogens. Step 4 is to consult infectious disease experts for patients with serious infections. Step 5 is to engage in local antimicrobial control. Step 6 is to know your antibiogram.

Step 7 is to treat infection, not contamination. Step 8 is to treat infection, not colonization. Step 9 is to know when to say "no” to vancomycin. Step 10 is to stop antimicrobial treatment when infection is treated or unlikely. Step 11 is to use standard infection control precautions, contain infectious body fluids, and consult infection control experts when in doubt. Step 12 is to break the chain of contagion by staying home when sick, keeping hands clean, and setting an example.

Antimicrobial resistant infections in healthcare settings are a major threat to patient safety. Each year in the United States alone, an estimated 2 million hospitalized patients acquire infections that result in more than 90,000 deaths. More than half are caused by bacteria that are resistant to at least one of the antimicrobials commonly used to treat those infections, says the CDC.

"We are confident that this campaign will help prevent the emergence and spread of antimicrobial resistance in healthcare settings and make healthcare in the United States even safer than it is today,” said Dr. Julie Gerberding, director of the CDC campaign.




Related Links:
CDC
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Rapid Cleaning Verification Tool
ProExpose Protein Detection Test
New
4K-3D NIR/ICG Video Endoscope
TIPCAM 1 Rubina
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.